EpiCypher, Tebu-bio Reach European Distribution Agreement | GenomeWeb

NEW YORK (GenomeWeb News) – Epigenetics tools firm EpiCypher today announced it has selected Tebu-bio as its distribution partner in Europe.

Tebu-bio will distribute Research Triangle Park, NC-based EpiCypher's epigenetics and chromatic biology research products. Tebu-bio is based in Le Perray, France and has offices in Belgium, Germany, Italy, the Netherlands, Denmark, Finland, Norway, Sweden, Portugal, Spain, and the UK.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Genome Research this week: vervet genome, tandem repeats affect gene expression in great apes, and more.

Wired's Sarah Zhang writes that the fight over who developed the CRISPR/Cas9 genome editing tool first underscores the history of parallel discoveries in science.

Recent research indicates that the benefit of having a number of scientists all living and working in a certain area is eroding.

Tomas Lindahl, Paul Modrich, and Aziz Sancar share this year's Nobel Prize in Chemistry for their studies of DNA repair mechanisms.